Molecular Partners Announces Research Collaboration with
Research collaboration with leading acute myeloid leukemia (AML) experts, Professor Ochsenbein and Professor Riether from the Department of Medical...
Source: globenewswire.com
Carsten Riether News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Carsten Riether. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Carsten Riether Today - Breaking & Trending Today
Molecular Partners to Host Oncology Day (Virtual)
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Molecular Partners to Host Oncology Day (Virtual)
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage...
Source: globenewswire.com
Molecular Partners to Host Oncology Day (Virtual)
15.12.2021 - ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Dec. 15, 2021 (GLOBE NEWSWIRE) - Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, ...
Source: wallstreet-online.de
Anti-emetic drug offers a promising approach to treat chronic myeloid leukemia
Anti-emetic drug offers a promising approach to treat chronic myeloid leukemia Chronic myeloid leukemia (CML) results from a degeneration of the hematopoietic stem cells (leukemia stem cells), thereby leading to the uncontrolled formation of specific white blood cells, the so-called granulocytes. Research work at the Department of Medical Oncology at the Inselspital, Bern University Hospital and the University of Bern focused therefore on identifying the signaling pathways and control mechanisms of the leukemia stem cell. A promising approach is provided by working with MPR, an anti-emetic me...
Source: news-medical.net